PATENT CLAIM ANALYSIS

Application Number: 16446098
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["514", "262100"]

Abstract:
The present invention provides heterocyclylamine derivatives of Formula I: wherein the variables are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.

Claim (Index 53):
A pharmaceutical composition comprising a compound of  claim 44 , or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 100.0
- Lexical Diversity: 1.41463
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14872881', '15673529', '16112160', '14872918', '13601349']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.807244110752359
- 35 USC 102 Novelty (BERT): 0.661297943477193
- Combined Prediction Score: 0.7926494940248424
- Mean Citation Score: 622.894354
- Max Citation Score: 758.6226
- Similarity Product: 595.0800161666392

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test